L’IA au soutien de la lutte contre la résistance aux médicaments
en-GBde-DEes-ESfr-FR

L’IA au soutien de la lutte contre la résistance aux médicaments

27/01/2025 SciDev.Net

Par: Dann Okoth

[NAIROBI] Des scientifiques ont développé un chatbot (un agent virtuel de conversation) basé sur l’intellience artificielle (IA), similaire à ChatGPT, pour aider les gouvernements à élaborer des politiques efficaces en matière de lutte contre la résistance aux médicaments, plus connue sous comme la résistance aux antimicrobiens (RAM).

La RAM est une situation où les bactéries et les virus responsables de maladies ne répondent plus aux médicaments conçus pour les traiter. Elle provoque des millions de décès par an et entraîne des coûts de santé pouvant atteindre 412 milliards de dollars par an, selon l’Organisation mondiale de la santé (OMS).

Dans les pays à revenu faible et intermédiaire, le manque d’assainissement, l’accès limité à des médicaments de qualité et l’utilisation inappropriée d’antibiotiques alimentent l’augmentation de la RAM, tandis que des maladies graves comme le VIH , la tuberculose et le paludisme deviennent plus difficiles à traiter.

Lire la suite

Attached files
  • L'intelligence artificielle pourrait aider à renforcer la lutte contre la RAM. Crédit image: Airam Dato-on (Pexels.com license)
27/01/2025 SciDev.Net
Regions: Africa, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Zambia, Zimbabwe, Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo, Congo, Republic of the, Côte d'Ivoire, Djibouti, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, Europe, United Kingdom
Keywords: Health, Public Dialogue - health, Applied science, Artificial Intelligence

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement